IASLC Position Statement on the Documentation of Tobacco Use in Cancer Clinical Trials
Position Statement | English
Image For Activity Cover
Credit Offered
No Credit Offered
IASLC recognizes it is critical that smoking information be collected and available for analysis to accurately assess the benefits and harms of cancer treatment in clinical trials.

Read the 2023 IASLC Position Statement for recommendations on how to advance knowledge on the impacts of tobacco smoke in the context of cancer clincial trials. 
Powered By